Skip to content

Dermatologic Manifestations of Zika Virus

Survey of Symptoms and Dermatologic Characterization Associated With Zika Virus

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03229421
Acronym
DMZV
Enrollment
0
Registered
2017-07-25
Start date
2017-07-06
Completion date
2018-12-31
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zika Virus Symptoms and the Associated Exanthema

Keywords

Zika Virus

Brief summary

The purpose of this study is to determine whether any diagnostic patterns exist in the symptom presentation of Zika Virus.

Detailed description

The study has both retrospective and prospective components. The retrospective review includes medical records with laboratory confirmed Zika Virus diagnosis and the prospective component will enroll adults presenting with febrile illness and rash and ask them to complete a survey about their symptoms. Diagnostic testing will be completed to confirm infection source.

Interventions

OTHERSurvey

18 question symptom assessment tool including non-identifying demographic information questions.

Sponsors

Pontificia Universidad Catolica Madre y Maestra
CollaboratorOTHER
Northwestern University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years and older presenting with febrile illness and rash

Exclusion criteria

* Patients aged 17 years or younger

Design outcomes

Primary

MeasureTime frameDescription
Number of days with specific symptoms20 minutesNumber of days reported experiencing specific symptoms due to Zika Virus infection and and associated characteristics such as location and intensity

Secondary

MeasureTime frameDescription
Frequency measures of initial clinical presentations20 minutesFrequency of reported symptoms at initial clinical presentation.

Countries

Dominican Republic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026